Atlas Trials

Efficacy and Safety of 1% Atropine "5+3" Regimen in Children and Adolescents Controlling Myopia

Clinical trial NCT05448989 · UNKNOWN

Trial details

NCT number
NCT05448989
Sponsor
Shanghai Eye Disease Prevention and Treatment Center
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Myopia
Start date
2022-01-01
Primary completion
2023-12-01
Enrollment
192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.